Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Spinosyn D
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Blepharitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 06, 2024
Lead Product(s) : Spinosyn D
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Concentrics Research | IQVIA | Medpace, Inc | Inotiv | BioAgilytix
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Scabies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 05, 2022
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Concentrics Research | IQVIA | Medpace, Inc | Inotiv | BioAgilytix
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Concentrics Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Details : Natroba (Spinosad) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Scabies.
Product Name : Natroba
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 30, 2015
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Concentrics Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Concentrics Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Details : Natroba (Spinosad) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Scabies.
Product Name : Natroba
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 30, 2015
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Concentrics Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Lice Infestations.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 08, 2012
Lead Product(s) : Spinosyn D
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable